VW5.F The Cannabist Company Holdings Inc.

Healthcare Drug Manufacturers - Specialty & Generic Frankfurt Exchange
0.0206 EUR
Close of Nov 12, 2026
0.0191 0.0999
Market cap
EUR 10.1M
P/E
-
P/B
4.67x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2025.

Is VW5.F undervalued?

Graham number

The Graham number of The Cannabist Company Holdings Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

The Cannabist Company Holdings Inc. fundamental analysis

No fundamental analysis for The Cannabist Company Holdings Inc. yet.

The Cannabist Company Holdings Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About The Cannabist Company Holdings Inc.

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company pro…

Full company profile